🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Kalifornija › Vallejo

Kliničke studije za Немалоклетни карцином плућа u gradu Vallejo, CA

10 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Vallejo i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Тражи се учесникФаза 3
  • Kaiser Permanente-Vallejo, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • Kaiser Permanente-Vallejo, Vallejo
  • Sutter Solano Medical Center/Cancer Center, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Тражи се учесникОпсервациона студија
  • Kaiser Permanente-Vallejo, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Тражи се учесникФаза 3
  • Kaiser Permanente Medical Center, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07185997

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Тражи се учесникФаза 3
  • Northern California Kaiser Permanente, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07195695

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Тражи се учесникФаза 3
  • Kaiser Permanente - Vallejo Medical Center, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07128199

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Sutter Solano Medical Center/Cancer Center, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Kaiser Permanente-Vallejo, Vallejo
  • Sutter Solano Medical Center/Cancer Center, Vallejo
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • Kaiser Permanente-Vallejo, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Kaiser Permanente-Vallejo, Vallejo
  • Sutter Solano Medical Center/Cancer Center, Vallejo
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Vallejo

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.